Cargando…
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy
BACKGROUND: Cancer remains a serious health concern worldwide, and different approaches are being developed for its treatment. The strategy to use the immune system as an approach for treating cancer has recently gained momentum. Messenger RNA (mRNA) has been assessed as an up-and-coming resource fo...
Autores principales: | Karmacharya, Prajeena, Patil, Basavaraj Rudragouda, Kim, Jong Oh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960215/ https://www.ncbi.nlm.nih.gov/pubmed/35369363 http://dx.doi.org/10.1007/s40005-022-00569-9 |
Ejemplares similares
-
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
por: Yang, Lei, et al.
Publicado: (2022) -
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
por: Guevara, Maria L., et al.
Publicado: (2020) -
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
por: Swetha, K., et al.
Publicado: (2023) -
Recent Advances in Site-Specific Lipid Nanoparticles
for mRNA Delivery
por: Xu, Xiao, et al.
Publicado: (2023) -
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
por: Wang, Hong-Li, et al.
Publicado: (2022)